Atlas Logo
Three-City Study (3C Study)
Three-City Study logo
BACK
Sample details

3C study recruited elderly adults from three areas of France: Bordeaux in the South West, Dijon in the North East, and Montpellier in the South East. Eligible participants were at least 65 years old and not institutionalized. This resulted in a baseline cohort of over 9,600 individuals.

Study design
Cohort

Number of participants at first data collection

9,693 (participants)

Age at first data collection

≥ 65 years (participants)

Participant year of birth

Varied (participants)

Participant sex
All

Representative sample at baseline?
No

Sample features

Older and elderly people
Dataset details

Country

France

Year of first data collection

1999

Primary Institutions

Institut national de la santé et de la recherche médicale (Inserm)

University of Bordeaux (Université de Bordeaux)

Links

three-city-study.com/

neurodegenerationresearch.eu/cohort/the-three-city-study/

doi.org/10.1371%2Fjournal.pone.0252500

Profile paper DOI

doi.org/10.1159/000072920

Funders

Medical Research Foundation (Fondation pour la Recherche Médicale, FRM)

National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale, INSERM)

Sanofi-Synthélabo (now known as Sanofi)

University of Bordeaux

Ongoing?
No

Data types collected

neuroImagingData
mentalHealthData
dataLinkage
Quantitative data collection
  • Activity log (e.g. food, sleep, exercise)
  • Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
  • Interview – face-to-face
  • Secondary data
  • Self-report questionnaire – unspecified
Qualitative data collection
  • None
Neuroimaging data collection
  • Magnetic Resonance Imaging (MRI)
Linked or secondary data
  • Healthcare data
Features

Engagement

  • None
  • Keywords

    Ageing
    Alzheimer's disease (AD)
    Biological samples/biospecimens
    Cognitive ageing and decline
    Dementia
    Elderly
    Mild cognitive impairment (MCI)
    Parkinson's disease (PD)
    Contact us

    |

    FAQS

    |

    Privacy

    |

    © 2024 Louise Arseneault

    Platform by Delosis